Status:

UNKNOWN

Spinal Cord Stimulation Efficacy Measures

Lead Sponsor:

New York Neurosurgery & Neuroscience Associates, PLLC

Collaborating Sponsors:

MedtronicNeuro

Conditions:

Chronic Pain in the Trunk and Limbs

Eligibility:

All Genders

18+ years

Phase:

PHASE1

Brief Summary

The purpose of the study is to measure the efficacy of varying spinal cord stimulation frequencies and pulse-width settings on chronic pain management. The spinal cord stimulator settings that are mos...

Detailed Description

For a total of 9 weeks, patients will be randomized to 9 stimulation frequency and pulse-width setting combinations. The patient will stay with these settings for a week at a time. Prior to the patien...

Eligibility Criteria

Inclusion

  • The patient must have SCS implanted for at least 2 months before study start date
  • The patient must be at least 18 years old
  • The patient must currently be receiving pain relief from SCS usage
  • The patient must be willing to participate in a 9-week study
  • The patient must have at least 20% of battery life remaining in his/her spinal cord stimulator
  • The patient must be able to tolerate Vicodin-Extra Strength as well as Tylenol, but can also take their own pain medication if it is not one of the two mentioned

Exclusion

  • The patient is pregnant or intends to become pregnant during the course of the study.
  • The patient by report, and/or by physician assessment, exhibits any or all of the following, which might bias reporting of treatment outcome:
  • A strong untreated dependency on prescription medication such as benzodiazepines and narcotic analgesics.
  • A strong potential for secondary gain issues.
  • A significant, untreated psychiatric comorbidity.
  • The patient possesses a coexisting clinically relevant or disabling chronic pain problem not treated by SCS
  • The patient has been diagnosed with unstable angina
  • The patient receives a Karnofsky's performance score of \<60

Key Trial Info

Start Date :

May 1 2006

Trial Type :

INTERVENTIONAL

End Date :

August 1 2006

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT00351208

Start Date

May 1 2006

End Date

August 1 2006

Last Update

July 12 2006

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

The Brookdale University Hospital and Medical Center

Brooklyn, New York, United States, 11212

2

New York Neurosurgery & Neuroscience Associates, PLLC

Rockville Centre, New York, United States, 11570